Int Conf AIDS. 1998;12:1018 (abstract no. 60099). Unique Identifier :
OBJECTIVES: HIV/AIDS records indicate, that now no intravenous drug
users (ivdu) were found in Hungary. The National Statistical Data
Collection Program's Report on the treatment of drug addicts indicate
that the number of those in treatment doubled between 1994 and 1996, the
rate of opiate (heroin) users is one of the increase, as well, as the
rate of injecting drug users (in 1996 it was 998). However this figure
is far from those of other countries with more serious drug problems,
the trends are worrying. Therefore the Interministrial Drug Committee
and the National AIDS Committee of Hungary decided to set up a joint
program on sentinel surveillance among at risk populations. A total
number of 4233 drug users were treated in 164 different treatment
settings throughout Hungary, and 935 of them was reported as intravenous
drug user, the target population of our investigation was the above risk
group of VDU's. METHODS: We informed all of those who treat ivdu's and
40 treatment places (from different regions of the country) participated
in this voluntary testing program. More than 400 saliva collection
device from SDS (Saliva Diagnostic Systems) were disseminated. This is
good to avoid the needle-caused injury of the vein. RESULTS: During 1997
145 saliva samples and 180 blood samples were sent to the laboratory for
HIV, HBsAg and HCV investigation, both from saliva and blood. 0/145
HIV+; 0/145 HBsAg+; and 22/145 HCV+ (16%) results were found from the
saliva samples. 0/180 HIV+; 5/180 HBsAg+ (2.7%) 3/180 HBsAg
indeterminate (1.6%) and 28/180 HCV+ (16%) results were found from blood
samples. CONCLUSION: Our findings indicate, that no HIV infection was
found among the 32% of the target population. The prevalence of HCV
infection in the investigated population was 16%, significantly less,
than in majority of Central-European and EU member countries (where the
HCV infection among ivdu's is rather high, in some cases between 50-75%.
From this conclusion can be drawn: needle sharing seems to be on a low
level, which is indicated also by incidental information coming from
physicians.
MEETING ABSTRACTS Comorbidity Cross-Sectional Studies Hepatitis
B/*EPIDEMIOLOGY Hepatitis B Surface Antigens/ANALYSIS Hepatitis
C/*EPIDEMIOLOGY Human Hungary HIV Infections/*EPIDEMIOLOGY Incidence
Substance Abuse, Intravenous/*EPIDEMIOLOGY